Kessler H - Search Results

1

Docking studies on alphavbeta3 integrin ligands: pharmacophore refinement and implications for drug design.

Marinelli L, Lavecchia A, Gottschalk KE, Novellino E, Kessler H. Marinelli L, et al. Among authors: kessler h. J Med Chem. 2003 Oct 9;46(21):4393-404. doi: 10.1021/jm020577m. J Med Chem. 2003. PMID: 14521404

2

Conformation/activity studies of rationally designed potent anti-adhesive RGD peptides.

Gurrath M, Müller G, Kessler H, Aumailley M, Timpl R. Gurrath M, et al. Among authors: kessler h. Eur J Biochem. 1992 Dec 15;210(3):911-21. doi: 10.1111/j.1432-1033.1992.tb17495.x. Eur J Biochem. 1992. PMID: 1483474 Free article.

3

Comparison of the conformation of active and nonactive backbone cyclic analogs of substance P as a tool to elucidate features of the bioactive conformation: NMR and molecular dynamics in DMSO and water.

Grdadolnik SG, Mierke DF, Byk G, Zeltser I, Gilon C, Kessler H. Grdadolnik SG, et al. Among authors: kessler h. J Med Chem. 1994 Jul 8;37(14):2145-52. doi: 10.1021/jm00040a005. J Med Chem. 1994. PMID: 7518522

4

Pharmacophore refinement of gpIIb/IIIa antagonists based on comparative studies of antiadhesive cyclic and acyclic RGD peptides.

Müller G, Gurrath M, Kessler H. Müller G, et al. Among authors: kessler h. J Comput Aided Mol Des. 1994 Dec;8(6):709-30. doi: 10.1007/BF00124017. J Comput Aided Mol Des. 1994. PMID: 7738606

5

Selective recognition of cyclic RGD peptides of NMR defined conformation by alpha IIb beta 3, alpha V beta 3, and alpha 5 beta 1 integrins.

Pfaff M, Tangemann K, Müller B, Gurrath M, Müller G, Kessler H, Timpl R, Engel J. Pfaff M, et al. Among authors: kessler h. J Biol Chem. 1994 Aug 12;269(32):20233-8. J Biol Chem. 1994. PMID: 8051114 Free article.

6

Synthesis of Dolastatin 15 mimetic peptoids.

Schmitt J, Bernd M, Kutscher B, Kessler H. Schmitt J, et al. Among authors: kessler h. Bioorg Med Chem Lett. 1998 Feb 17;8(4):385-8. doi: 10.1016/s0960-894x(98)00034-1. Bioorg Med Chem Lett. 1998. PMID: 9871690

7

N-Methylated cyclic RGD peptides as highly active and selective alpha(V)beta(3) integrin antagonists.

Dechantsreiter MA, Planker E, Mathä B, Lohof E, Hölzemann G, Jonczyk A, Goodman SL, Kessler H. Dechantsreiter MA, et al. Among authors: kessler h. J Med Chem. 1999 Aug 12;42(16):3033-40. doi: 10.1021/jm970832g. J Med Chem. 1999. PMID: 10447947

8

Solid-phase synthesis of a nonpeptide RGD mimetic library: new selective alphavbeta3 integrin antagonists.

Sulyok GA, Gibson C, Goodman SL, Hölzemann G, Wiesner M, Kessler H. Sulyok GA, et al. Among authors: kessler h. J Med Chem. 2001 Jun 7;44(12):1938-50. doi: 10.1021/jm0004953. J Med Chem. 2001. PMID: 11384239

9

Design and synthesis of potent and selective alpha(4)beta(7) integrin antagonists.

Boer J, Gottschling D, Schuster A, Semmrich M, Holzmann B, Kessler H. Boer J, et al. Among authors: kessler h. J Med Chem. 2001 Aug 2;44(16):2586-92. doi: 10.1021/jm0005508. J Med Chem. 2001. PMID: 11472212

10

Cellular solid-phase binding assay and mass spectrometry for screening of alpha 4 beta 7 integrin antagonists.

Gottschling D, Boer J, Schuster A, Holzmann B, Kessler H. Gottschling D, et al. Among authors: kessler h. Bioorg Med Chem Lett. 2001 Dec 3;11(23):2997-3000. doi: 10.1016/s0960-894x(01)00611-4. Bioorg Med Chem Lett. 2001. PMID: 11714596

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,224 results

Search Page

Filters